EUVIMEDEUVIMED entdecken
Beobachtungsstudie

β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients

Alexandra Greco Kinney, Nicole Kovacic Scherrer, Sauradeep Sarkar, Pranav Jain, Sijin Wen, Sarah Hadique

Journal of Antimicrobial Chemotherapy · 01.12.2023 · 78 (12) · 2816-2823

DOI: 10.1093/jac/dkad301 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 10.10.2023. Verfasst von Alexandra Greco Kinney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, WVU Medicine, Morgantown, WV, USA. Hauptthemen laut MEDLINE: Pneumonia, Community-Acquired Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Community-acquired pneumonia (CAP) is a significant source of hospital admissions and mortality. Atypical organisms are implicated in up to 40% of cases of CAP diagnoses. We studied the difference in outcomes of severe CAP patients treated with doxycycline versus azithromycin in addition to β-lactam therapy. Patients and methods This was a prospective observational cohort study from March 2020 to July 2022 in a medical ICU (MICU) of an academic quaternary medical center. Adults ≥18 years admitted to the MICU receiving doxycycline or azithromycin in addition to β-lactam therapy for the treatment of CAP were included for analysis. The primary outcomes were in-hospital and 30 day mortality. Secondary outcomes were ICU and hospital length-of-stay, 30 day readmission, days of mechanical ventilation, escalation and duration of antibiotics, adverse effects such as Clostridioides difficile infection and QTc prolongation.

Results

Sixty-three patients were in the azithromycin group and eighty-six patients in the doxycycline group. Both groups had similar APACHE IV and CURB-65 scores. The mean Charlson Comorbidity Index score was higher for the doxycycline group compared with the azithromycin group (P = 0.04). There was no statistically significant difference in in-hospital and 30 day mortality between the groups (P = 0.53, P = 0.57). There were no significant differences in any of the secondary outcomes.

Conclusions

MICU patients with severe CAP who received doxycycline versus azithromycin in addition to β-lactam treatment showed no significant differences in outcomes. These data offer support for inclusion of doxycycline as an alternative regimen in current IDSA recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumoniaCommunity-Acquired InfectionsAdultHumansAzithromycinDoxycyclinebeta-LactamsProspective StudiesCritical IllnessDrug Therapy, CombinationAnti-Bacterial AgentsTreatment Outcome

Substanzen

AzithromycinDoxycyclinebeta-LactamsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, WVU Medicine, Morgantown, WV, USA.
  • Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, West Virginia University, Morgantown, WV, USA.
  • Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Department of Epidemiology and Biostatistics, West Virginia University, Morgantown, WV, USA.

Zitieren

APA

Greco Kinney, A., Kovacic Scherrer, N., Sarkar, S., Jain, P., Wen, S., & Hadique, S. (2023). β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients. Journal of Antimicrobial Chemotherapy, 78(12), 2816-2823. https://doi.org/10.1093/jac/dkad301

Vancouver

Greco Kinney A, Kovacic Scherrer N, Sarkar S, Jain P, Wen S, Hadique S. β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients. Journal of Antimicrobial Chemotherapy. 2023;78(12):2816-2823. doi:10.1093/jac/dkad301

BibTeX
@article{GrecoKinney2023,
  author = {Greco Kinney, Alexandra and Kovacic Scherrer, Nicole and Sarkar, Sauradeep and Jain, Pranav and Wen, Sijin and Hadique, Sarah},
  title = {β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  volume = {78},
  number = {12},
  pages = {2816--2823},
  doi = {10.1093/jac/dkad301}
}
Kostenlos starten →